Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Models trained on public repositories like ChEMBL achieve high accuracy merely by predicting the creator of a molecule from its structure rather than learning chemical physics. Replacing molecular formulas with a vector indicating the probability of the chemist author yields identical predictive performance on target activity.

Related Insights

To evolve AI from pattern matching to understanding physics for protein engineering, structural data is insufficient. Models need physical parameters like Gibbs free energy (delta-G), obtainable from affinity measurements, to become truly predictive and transformative for therapeutic development.

Unlike traditional methods that simulate physical interactions like a key in a lock, ProPhet's AI learns the fundamental patterns governing why certain molecules and proteins interact. This allows for prediction without needing slow, expensive, and often impossible physical or computational simulations.

Similar to how an LLM uses a 'chain of thought' to reason, Genesis's model 'thinks' by iteratively refining an in-memory representation of a crystal structure. This process is guided by physics-based principles, significantly improving the final prediction's accuracy.

Because DNA encoded libraries are built combinatorially from building blocks, millions of molecules differ by only one or two changes. This structured variation enables machine learning models to isolate exactly which chemical fragments drive target binding while keeping the rest of the molecule constant.

In a direct comparison, a medicinal chemist was better than an AI model at evaluating the synthesizability of 30,000 compounds. The chemist's intuitive, "liability-spotting" approach highlights the continued value of expert human judgment and the need for human-in-the-loop AI systems.

Sorting public dataset molecules by molecular weight alone matches top machine learning models in binding prediction. This correlation arises purely from chemist behavior: as a starting molecule shows activity, chemists iteratively tack on functional groups to optimize affinity and solubility, inflating the size of active compounds.

Despite testing millions of compounds, high-throughput screening methods suffer from enormous false-positive rates. The actual predictive value for a re-synthesized molecule is extremely low, creating an opening for high-fidelity AI models to provide cleaner, more reliable predictions.

In a 2,000-team Kaggle challenge using a 4-billion interaction dataset, models performed adequately when test molecules shared building blocks or core hubs with the training set. However, when evaluated against completely orthogonal chemical libraries with distinct chemistry, no model beat random chance.

Unlike fields with vast training data like image recognition, effective drug discovery has too few successful examples for AI to learn from alone. To be useful, AI models must be explicitly taught the foundational principles and complex rules of medicinal chemistry that human experts use.

As neural network parameter counts grow, direct numerical models risk memorizing complex mutant variations and individual building blocks. Representing molecules, targets, and structural differentials in natural English provides an inductive bias and regularizer that helps agents learn causal structure-activity relationships instead.

Machine Learning Models Predict Molecule Activity by Inferring Chemist Sociology Instead of Physics | RiffOn